Dr. Reddy's works on quality; Patheon to manufacture Flexion product;

> Executives of Dr. Reddy's Laboratories says the company is investing in its quality systems to meet FDA standards. Report

> Flexion Therapeutics ($FLXN) hired Patheon to manufacture its steroid candidate. Report

> AAIPharma Services Corp./Cambridge Major Laboratories will manufacture the API for Atossa Genetics' ($ATOS) drug candidate. Report

> A new report says the global ampoules and blister packaging market hit $10.3 billion last year and will grow 6.24% CAGR for the next 5 years to hit $14.8 billion. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.